Stock A183490 ENZYCHEM LIFESCIENCES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Company Enzychem Lifesciences Corporation

Equities

A183490

KR7183490002

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 03/07/2024 am IST 		5-day change 1st Jan Change
1,800 KRW +0.95% Intraday chart for Enzychem Lifesciences Corporation -10.22% -0.99%
05/04 Enzychem Lifesciences Corporation announces an Equity Buyback for KRW 10,000 million worth of its shares. CI
05/04 Enzychem Lifesciences Corporation authorizes a Buyback Plan. CI

Business Summary

ENZYCHEM LIFESCIENCES CORPORATION is a Korea-based Company mainly engaged in the development and manufacture of medical raw materials. The Company provides D-cycloserine, a synthetic product utilizing chiral technology to treat tuberculosis; antibiotics, such as terizidone, cefbuperazone, cefazedone and others; magnetic resonance imaging (MRI) contrast agents such as gadoterate and gadopentate; others for antithrombotic drugs, antiinflammatory analgesic drugs, and drugs for gastric ulcer and hyperlipidemia. The Company also provides functional health food and finished drug products.

Number of employees: 113

Sales per Business

KRW in Million2022Weight2023Weight Delta
Bio - Maintenance
53.8 %
- - 40,927 53.8 % -
Drug Substance Other Product
45.0 %
25,630 96.2 % 34,181 45.0 % +33.36%
Health Functional Food Product
1.2 %
1,007 3.8 % 931 1.2 % -7.58%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
93.3 %
23,868 89.6 % 70,907 93.3 % +197.08%
Overseas
6.7 %
2,770 10.4 % 5,132 6.7 % +85.30%

Managers

Managers TitleAgeSince
Gi-Young Sohn CEO
 Chief Executive Officer 62 01/12/01
Do-Hyeon Jo COO
 Chief Operating Officer 49 21/16/21
Myung-Hwan Kim BRD
 Director/Board Member 67 01/15/01
Jae-Yong Lee BRD
 Director/Board Member 62 01/11/01
Hwang-Bae Kang AUD
 Comptroller/Controller/Auditor 58 30/15/30

Members of the board

Members of the board TitleAgeSince
Gi-Young Sohn CEO
 Chief Executive Officer 62 01/12/01
Hye-Kyung Kim BRD
 Director/Board Member 66 01/12/01
Jae-Yong Lee BRD
 Director/Board Member 62 01/11/01
Myung-Hwan Kim BRD
 Director/Board Member 67 01/15/01
Do-Hyeon Jo COO
 Chief Operating Officer 49 21/16/21
Chang-Ki Hong BRD
 Director/Board Member 87 26/19/26
Hye-Young Oh BRD
 Director/Board Member 68 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 85,065,562 74,031,725 ( 87.03 %) 0 87.03 %

Shareholders

NameEquities%Valuation
Bridget Lifesciences Corp.
7.456 %
6,342,830 7.456 % 9 M ₩
KB Securities Co., Ltd.
4.937 %
4,200,056 4.937 % 6 M ₩
Gi-Young Sohn
4.784 %
4,069,430 4.784 % 6 M ₩
Young-bae Yoon
0.3143 %
267,358 0.3143 % 370 753 ₩
Jong-soo Lee
0.1347 %
114,600 0.1347 % 158 919 ₩
Hye-Kyung Kim
0.0750 %
63,810 0.0750 % 88 487 ₩
Jae-Han Jung
0.0200 %
17,040 0.0200 % 23 630 ₩
Jae Ho Choi
0.0173 %
14,707 0.0173 % 20 395 ₩
Tae-hun Kim
0.009254 %
7,872 0.009254 % 10 916 ₩
Dong-seong Kim
0.007406 %
6,300 0.007406 % 8 736 ₩

Company contact information

ENZYCHEM LIFESCIENCES Corp.

59 Bio Valley-ro

34051, Jecheon-si

+

http://www.enzychem.com
address Enzychem Lifesciences Corporation(A183490)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
ENZYCHEM LIFESCIENCES CORPORATION Stock Enzychem Lifesciences Corporation
-0.99% 109M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+54.07% 816B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+38.59% 634B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.05% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.44% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.72% 293B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.40% 238B
ROCHE HOLDING AG Stock Roche Holding AG
+0.61% 222B
NOVARTIS AG Stock Novartis AG
+13.24% 218B
AMGEN INC. Stock Amgen Inc.
+7.42% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A183490 Stock
  4. Company Enzychem Lifesciences Corporation